Hippotherapy improves balance and mobility

Trial ID
NCT06500182
Official Title
The Benefits of Hippotherapy for Patients With Parkinson's Disease of 75 Years of Age or More at Risk of Losing Their Independance.
Goal
Hippotherapy improves balance and mobility
Phase
NA
Status
RECRUITING
Sponsor
Central Hospital Saint Quentin
Study Type
INTERVENTIONAL
Enrollment
36 participants
Conditions
Parkinson Disease
Interventions
hippotherapy sessions

Plain-Language Summary

A program of therapeutic horse riding uses the horse’s gentle, rhythmic movement to stimulate balance, posture and gait, with the goal of helping people 75 and older with Parkinson’s keep or slow the loss of independence. The sessions are given in addition to usual Parkinson’s medications, so hippotherapy is intended to complement levodopa or other drugs by improving motor control and mobility rather than replacing medication. The study is looking for people aged 75 or over with Parkinson’s who can give informed consent, have preserved autonomy and no major cognitive or behavioral problems, are not under guardianship, and have no contraindication to MRI or to participating in horse riding.

Locations

  • Centre Hospitalier de Saint-Quentin;, Saint-Quentin, Aisne, France

Frequently Asked Questions

What is this trial testing?
This trial is studying hippotherapy sessions. A program of therapeutic horse riding uses the horse’s gentle, rhythmic movement to stimulate balance, posture and gait, with the goal of helping people 75 and older with Parkinson’s keep or slow the loss of independence. The sessions are given in addition to usual Parkinson’s medications, so hippotherapy is intended to complement levodopa or other drugs by improving motor control and mobility rather than replacing medication. The study is looking for people aged 75 or over with Parkinson’s who can give informed consent, have preserved autonomy and no major cognitive or behavioral problems, are not under guardianship, and have no contraindication to MRI or to participating in horse riding.
Who can participate?
Participants must be at least 75 Years.
Where is this trial located?
This trial is recruiting at 1 location.
Does it cost anything to join?
No. There is no cost to participate. Study-related care and treatment are provided at no charge.
How long does the trial last?
This trial is estimated to last approximately 1 year.

View on ClinicalTrials.gov